Hemerocallis citrina
Hemerocallis citrina · Accepted scientific name
Scientific literature: Very Sparse (0 studies) · ★☆☆☆☆
Hemerocallis citrina is a distinctive plant species known for its unique biological profile and medicinal potential. The plant contains several significant chemical compounds, including flavonoids, aloe emodin, chrysophanol, and 2-methoxy-obtusifolin. Researchers typically focus their studies on the plant's flower and root to understand its full therapeutic scope. Various preparations are utilized in scientific evaluations, such as HCE30%, HCE50%, and HCN. Through these specific extractions, the plant's complex chemical properties can be more effectively analyzed.
- Synonyms
- Not available
- Common names
- Not available
- Family
- Asphodelaceae
- Distribution
- Not available
- Plant Parts
- Flower · Root
Classification
Common Names
Hemerocallis citrina is a distinctive plant known widely by its English common name, the Citron Day-lily. This species is recognized across various languages, appearing as Liliowiec cytrynowy in Polish contexts. In Scandinavian regions, it is referred to as blekgul daglilja or citrongul daglilje. It also carries the designation denivka citrónová in Slovak terminology. These diverse names highlight the global presence and linguistic variety associated with this beautiful flowering plant.
Sources: Catalogue of Life (COL)
Taxonomy
Hemerocallis citrina belongs to the vast kingdom Plantae, representing the diverse world of multicellular organisms. Within this group, it is classified under the class Equisetopsida, marking its place among the flowering plants. This species falls into the order Asparagales, a lineage known for its distinct botanical characteristics. It is further categorized into the family Asphodelaceae, which defines its specific structural traits. Finally, its taxonomic journey concludes within the genus Hemerocallis, identifying it as a unique member of the daylily group.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Asparagales |
| Family | Asphodelaceae |
| Genus | Hemerocallis |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Hemerocallis citrina is a resilient species primarily found throughout the Asia-Temperate region. Its natural range extends extensively across various provinces in China, including the North-Central, South-Central, and Southeast territories. Additionally, this plant can be discovered within the expansive landscapes of Inner Mongolia. Beyond mainland China, its distribution reaches into Eastern Asia, specifically flourishing in the islands of Japan. This wide geographical spread highlights the plant's ability to adapt to diverse environmental conditions across the continent.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Morphology
Hemerocallis citrina is a self-supporting herb characterized by its sturdy and upright growth form. This resilient plant maintains its structure independently, allowing it to flourish within its natural environment.
Sources: Global Inventory of Floras and Traits (GIFT)
Biological Activities
Compounds
Hemerocallis citrina is a plant rich in diverse chemical constituents that contribute to its complex biological profile. Detailed studies of its roots have successfully isolated specific compounds such as 2-Methoxy-obtusifolin, aloe emodin, and chrysophanol. In addition to these specific molecules, the plant also contains hemerocallin, further diversifying its chemical makeup. Research into the flowers of the species highlights the presence of flavonoids, which play a significant role in its medicinal properties. Together, these various substances underscore the significant phytochemical potential found within different parts of Hemerocallis citrina.
Conditions
Hemerocallis citrina demonstrates significant therapeutic potential in treating human genetic neurodegenerative diseases, specifically Frontotemporal Dementia with Parkinsonism associated to chromosome 17 (FTDP-17) and Machado-Joseph Disease/Spinocerebellar Ataxia type 3 (MJD/SCA3). In animal models, extracts of the plant have been shown to ameliorate the motor deficits associated with these specific conditions. Furthermore, the plant provides neuroprotective benefits by reversing neurotoxicity induced by corticosterone in cell models. It also effectively treats neurotoxicity caused by glutamate through a dose-dependent mechanism. These protective effects are largely attributed to active phenolic constituents, such as flavonoids and phenolic acid derivatives, found within the plant.
Preparations
Hemerocallis citrina is prepared as three distinct types of extracts for therapeutic testing in vivo. Specifically, the plant is processed to create HCE30% and HCE50% extracts. Additionally, the plant is prepared as HCN to evaluate its potential against neurodegenerative diseases. These specific formulations, including HCE30%, are used to study motor deficits and serotonergic signaling in animal models. By utilizing HCE30%, HCE50%, and HCN, researchers can investigate the medicinal properties of this herbaceous perennial.
Parts used
Hemerocallis citrina is a versatile plant that serves both medicinal and edible purposes through its various anatomical components. Scientific analysis of the flowers reveals a rich concentration of bioactive flavonoids, which can be used to distinguish between edible and non-edible accessions. These floral extracts have also demonstrated significant neuroprotective potential by influencing the release of essential neurotransmitters. Beyond the blossoms, the plant's root contains a unique profile of chemical constituents, including several compounds identified through specialized extraction methods. Together, the metabolic diversity found in both the flowers and the roots highlights the complex biological value of this species.